Fig. 2From: Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancera Significant clinical-pathological correlations for TYMS expression in NSCLC patients. With respect to the type of response, tumors were categorized as either responding (CR, complete response or PR, partial response) or non-responding (SD, stable disease or PD, progressive disease). b Close-to-significance correlationsBack to article page